1. Eric A. Swanson

    0 Comments Related Articles

    1. Login to comment.

  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. About Eric A. Swanson

    Eric A. Swanson

    Eric Swanson is an active participant in a variety of entrepreneurial, industrial, academic, and volunteer activities. He serves on the board of directors for Acacia Communications, NinePoint Medical, Curata, and the Danish National Quantum Innovation Center and is an affiliate of the MIT Deshpande Center for Entrepreneurship. He is a cofounder or founding board member of five startup companies: Advanced Ophthalmic Devices (an ophthalmic OCT company), Lightlab Imaging (a cardiovascular OCT company), Sycamore Networks, Acacia Communication, and Curata. Mr. Swanson worked at MIT Lincoln Laboratory for 16 years where he collaborated in the discovery and advancement of OCT and worked on optical networks (including one of the first wavelength division multiplexed all-optical networks) and space communication (including one of the first intersatellite laser communication systems).

  3. Quotes

    1. Today, interdisciplinary research in biomedical optics is the standard. “And that was less common 25 years ago. A lot of innovation happens at the boundaries of disciplines. OCT is such a rich combination of disciplines—in optics, mechanical systems, electronics, software, medical devices, clinical medicine. That’s one of the reasons there’s been so much innovation in OCT, and that there’s so much more to come.
      In OSA Centennial Snapshots: OCT and the Flowering of Biophotonics
    2. I think OCT is one of the most important developments in diagnostic ophthalmic imaging in the history of ophthalmology, ranking up there with the invention of the ophthalmoscope in the 1800s. OCT has become a standard of care in ophthalmology and has helped diagnose various eye conditions for millions of people worldwide and proven to be a major sight-saver. In addition to OCT functioning as a unique, high-resolution, general-purpose ophthalmic diagnostic tool, OCT has played an important role in the development of new pharmaceuticals as well as the management of various macular diseases, glaucoma and corneal disease. One very important impact of OCT is that it enables nonspecialists, such as comprehensive ophthalmologists or optometrists, to detect early disease at a level approaching retinal or glaucoma specialists. OCT generated more than $1 billion of reimbursement worldwide in 2010 alone, has imaged ~100 million people over the past decade and generated over a billion of dollars in capital equipment revenue. Ophthalmic OCT technology and applications continue to develop at a rapid clip and the future looks very bright for continued impact on improved patient care.
      In Finding “Big Ideas” in Ophthalmic Innovation - Venture Capitalists Will Back Potential “Game Changers”
    3. Today there are over 10 companies supplying OCT systems for the ophthalmology and optometry markets. These companies are in fierce fights for market share and are investing lots of development dollars to achieve differentiation and drive sales...As a result, there have been numerous advances in speed, accuracy, higher lateral resolution, higher longitudinal resolution, image processing, compactness, ease of use, functional imaging (e.g., Doppler detection) and lowering capital equipment costs. This has brought, and will continue to bring, benefits to both physicians and end patients.
      In Ophthalmic Lasers Expand from Surgery to Detection and Diagnosis
    4. I am excited to join NinePoint Medical’s board and continue to build on my experience working with startups composed of great people, great technology, great market opportunities and, most importantly, the potential to make a major impact. NinePoint Medical is at an exciting stage, and its technology platform has the potential to greatly improve the diagnostic and treatment options available to the medical community...I look forward to working closely with the rest of the board and management team to move NinePoint’s innovative technology forward in development.
      In NinePoint Medical Adds Optical Coherence Tomography Technology Expert to Board of Directors
    5. I am excited to join NinePoint Medical's board and continue to build on my experience working with startups composed of great people, great technology, great market opportunities and, most importantly, the potential to make a major impact. NinePoint Medical is at an exciting stage, and its technology platform has the potential to greatly improve the diagnostic and treatment options available to the medical community.
      In NinePoint Medical Adds Optical Coherence Tomography Technology Expert to Board of Directors
    6. Eye On OCT is the first and only site of its kind for the eye care industry....As a leader in OCT innovation for nearly two decades, it is logical for Carl Zeiss Meditec to deliver a practical resource for clinicians and researchers who seek to stay abreast of the latest developments in OCT technology
      In Carl Zeiss Meditec Launches "Eye On OCT"